copanlisib | |
---|---|
Trade Name | |
Orphan Indication | Extranodal marginal zone lymphoma |
USA Market Approval | USA |
USA Designation Date | 2017-02-07 00:00:00 |
Sponsor | Bayer HealthCare Pharmaceuticals, Inc.;100 Bayer Boulevard, P. O. Box 915;Hanover, New Jersey, 07981 |